Inder Kaul - Concepedia

Author

Inder Kaul

Asahi Kasei (United States)

Also Known As

I Kaul, I. Kaul, Inder Kaul

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Asahi Kasei (United States)Sage Therapeutics (United States)Loyola University Chicago Bristol-Myers Squibb (United States)Indiana University – Purdue University Indianapolis

About

Inder Kaul is an author at Asahi Kasei (United States) specializing in medicine, medical laboratory science, and sepsis phenotyping.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	285
2	Emergency Medicine	2	2	67
3	Health Sciences	1	1	26
4	Social Sciences	1	1	192
5	Clinical Nutrition	1	1	26

Inder Kaul

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation* Jean‐Louis Vincent, M Ramesh, David Ernest, Critical Care Medicine	2013	315
Trial of SAGE-217 in Patients with Major Depressive Disorder Handan Gunduz-Bruce, Christopher Silber, Inder Kaul, New England Journal of Medicine	2019	224
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial Inder Kaul, Sharon Sawchak, Christoph U. Correll, The Lancet Flexible-dose Phase 3PsychiatryPsychotic DisorderMedicinePsychopharmacology	2023	192
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia Inder Kaul, Sharon Sawchak, David P. Walling, JAMA Psychiatry	2024	132
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies Ethan Hoffmann, George G. Nomikos, Inder Kaul, Clinical Pharmacokinetics	2019	58
Thrombin Generation Mediators and Markers in Sepsis-Associated Coagulopathy and Their Modulation by Recombinant Thrombomodulin Debra Hoppensteadt, Kazuhisa Tsuruta, Josephine Cunanan, Clinical and Applied Thrombosis/Hemostasis Severe SepsisImmunologyThrombin-antithrombin ComplexSepsis-associated CoagulopathyInflammation	2013	38
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials William P. Horan, Steven D. Targum, Amy Claxton, Schizophrenia Research	2024	38
Dysregulation of Inflammatory and Hemostatic Markers in Sepsis and Suspected Disseminated Intravascular Coagulation Debra Hoppensteadt, Kazuhisa Tsuruta, Joe Hirman, Clinical and Applied Thrombosis/Hemostasis ImmunologyInflammationThrombosisTranslational MedicineLaboratory Hematology	2013	29
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study Amy Bullock, Inder Kaul, Sigui Li, Journal of the Neurological Sciences	2020	27
Serum sialic acid levels in healthy individuals. V K Hangloo, Inder Kaul, HU Zargar PubMed Metabolic SyndromeNutritionHealthy IndividualsSialic Acid LevelsHealth Sciences	1990	26

Page 1